12-53424408-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_020547.3(AMHR2):āc.170A>Gā(p.Tyr57Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,682 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000013 ( 0 hom., cov: 32)
Exomes š: 0.0000034 ( 0 hom. )
Consequence
AMHR2
NM_020547.3 missense
NM_020547.3 missense
Scores
2
10
7
Clinical Significance
Conservation
PhyloP100: 2.00
Genes affected
AMHR2 (HGNC:465): (anti-Mullerian hormone receptor type 2) This gene encodes the receptor for the anti-Mullerian hormone (AMH) which, in addition to testosterone, results in male sex differentiation. AMH and testosterone are produced in the testes by different cells and have different effects. Testosterone promotes the development of male genitalia while the binding of AMH to the encoded receptor prevents the development of the mullerian ducts into uterus and Fallopian tubes. Mutations in this gene are associated with persistent Mullerian duct syndrome type II. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMHR2 | NM_020547.3 | c.170A>G | p.Tyr57Cys | missense_variant | 2/11 | ENST00000257863.9 | NP_065434.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMHR2 | ENST00000257863.9 | c.170A>G | p.Tyr57Cys | missense_variant | 2/11 | 1 | NM_020547.3 | ENSP00000257863.3 | ||
AMHR2 | ENST00000379791.7 | c.170A>G | p.Tyr57Cys | missense_variant | 2/9 | 1 | ENSP00000369117.3 | |||
AMHR2 | ENST00000550311.5 | c.170A>G | p.Tyr57Cys | missense_variant | 2/11 | 1 | ENSP00000446661.1 | |||
AMHR2 | ENST00000553037.1 | n.131A>G | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152142Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250334Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135434
GnomAD3 exomes
AF:
AC:
4
AN:
250334
Hom.:
AF XY:
AC XY:
0
AN XY:
135434
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461422Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727008
GnomAD4 exome
AF:
AC:
5
AN:
1461422
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
727008
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74450
GnomAD4 genome
AF:
AC:
2
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 01, 2020 | DNA sequence analysis of the AMHR2 gene demonstrated a sequence change, c.170A>G, in exon 2 that results in an amino acid change, p.Tyr57Cys. This sequence change does not appear to have been previously described in patients with AMHR2-related disorders and has been described in the gnomAD database with a low population frequency of 0.0016% (dbSNP rs574868905). The p.Tyr57Cys change affects a highly conserved amino acid residue located in a domain of the AMHR2 protein that is known to be functional. The p.Tyr57Cys substitution appears to be deleterious using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to these evidences and the lack of functional studies, the clinical significance of the p.Tyr57Cys change remains unknown at this time. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;T;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;L;L
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;N;N
REVEL
Pathogenic
Sift
Benign
T;T;D
Sift4G
Benign
T;D;D
Polyphen
P;.;.
Vest4
MutPred
Gain of catalytic residue at L56 (P = 8e-04);Gain of catalytic residue at L56 (P = 8e-04);Gain of catalytic residue at L56 (P = 8e-04);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at